3502 type a genome sequence (ATCC)
Structured Review

3502 Type A Genome Sequence, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 335 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3502+genome+sequence/HCT116-SLC35F2-KO-c2/pmc11310924-143-21-20
Average 96 stars, based on 335 article reviews
Images
1) Product Images from "Exploring genomic diversity in Clostridium botulinum using DNA microarrays"
Article Title: Exploring genomic diversity in Clostridium botulinum using DNA microarrays
Journal: The botulinum journal
doi: 10.1504/tbj.2012.050195
Figure Legend Snippet: CGH results of outbreak-related type A1 strains Notes: The top track depicts each coding region sequence (CDS) in the C. botulinum strain ATCC 3502 genome sequence. Subsequent tracks depict log2 signal ratios of the reference strain (ATCC3502) compared to each test strain (indicated below each track). Regions whose presence varies among outbreak-pairs are circled and their genomic location relative to ATCC 3502 genome is depicted by a letter above the top track. Region A corresponds to a ferrichrome uptake system, region B corresponds to a restriction/modification system, and region C corresponds to a glycosyltransferase.
Techniques Used: Sequencing, Modification
Figure Legend Snippet: Scheme used to select probes for the Group I subtyping microarray Notes: A total of 225 probes were selected. 146 probes corresponding to strain variable regions of the ATCC 3502 genome sequence were selected based on CGH analysis using Group I types A, B, and F test strains. In silico analysis was used to select the remaining probes representing genes not present in ATCC 3502, specific for either OkraB or LanglelandF strains, or other specific genes of interest.
Techniques Used: Microarray, Sequencing, In Silico